Alkylating Agent-Related Acute Myeloid Leukemia

specific

Acute myeloid leukemia occurring as late complication of prior therapy with alkylating agents.

61

Centers

5

Active Trials

Cancer Funding

Top Centers for Alkylating Agent-Related Acute Myeloid Leukemia(61)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
71.5
2
NCI Comprehensive
High-Volume Research Center
71.5
371.5
4
NCI Comprehensive
High-Volume Research Center
71.5
5
NCI Comprehensive
High-Volume Research Center
71.5
6
NCI Comprehensive
49.0
749.0
849.0
9
NCI Comprehensive
49.0
10
NCI Comprehensive
49.0
11
NCI Comprehensive
49.0
12
NCI Comprehensive
49.0
13
NCI Comprehensive
49.0
1449.0
1549.0
16
NCI Comprehensive
49.0
1749.0
1849.0
1949.0
20
NCI Comprehensive
49.0
21
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
49.0
22
NCI Comprehensive
49.0
23
NCI Comprehensive
49.0
24
NCI Comprehensive
49.0
25
NCI Clinical
49.0
26
NCI Comprehensive
49.0
2749.0
28
NCI Comprehensive
49.0
2949.0
30
Cedars-Sinai CancerLos Angeles, CA
49.0
3149.0
32
NCI Comprehensive
49.0
3349.0
3449.0
35
NCI Comprehensive
49.0
36
NCI Comprehensive
49.0
37
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
49.0
3849.0
3949.0
4049.0
4149.0
42
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
49.0
4349.0
44
NCI Comprehensive
49.0
4549.0
4649.0
4749.0
4849.0
4949.0
5049.0
5149.0
5249.0
5349.0
5449.0
5549.0
5649.0
5749.0
58
BC CancerVancouver, BC
49.0
5949.0
6049.0
6149.0

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →